Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has provided an announcement.
Wai Chun Bio-Technology Ltd. announced a delay in the dispatch of its circular related to the issuance of new convertible bonds under a specific mandate. The circular, which includes important information for shareholders regarding the subscription and related transactions, will now be sent out by June 24, 2025, instead of the previously scheduled date. This delay may impact the company’s timeline for executing the proposed financial transactions, potentially affecting stakeholders’ planning and decision-making processes.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company is involved in the issuance of financial instruments, such as convertible bonds, to support its operations and strategic initiatives.
Average Trading Volume: 217,350
Technical Sentiment Signal: Hold
Current Market Cap: HK$21.95M
Find detailed analytics on 0660 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue